Todd Bauer, MD
Surgical Oncology · Charlottesville, VANPI 1568551034
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $4,329 of the $5,508 with a category attached, or 78.6%. Boehringer Ingelheim International GmbH accounts for 78.6% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2022 at $3,386 and has fallen 99.2% since, to $27 in 2024.
Across 18 payments — averaging $306.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim International GmbH$4K
- AVEO Pharmaceuticals, Inc.$1K
- Daiichi Sankyo Inc.$27
- Novartis$26
Across 4 payments — averaging $736.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Takeda Pharmaceuticals U.S.A., Inc.$3K
- Novartis$219
- Sanofi US Services Inc.$150
What the payments were for
- Consulting fees$1,00018%
- Speaking & faculty fees$4,32979%
- Food & beverage$1803%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim International GmbH | 13 | $4,329 |
| AVEO Pharmaceuticals, Inc. | 2 | $1,127 |
| Daiichi Sankyo Inc. | 1 | $27 |
| Novartis | 2 | $26 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FOTIVDA$1,127
How this compares
$5,508 in reported general payments places this provider in the 70th percentile of 28 surgical oncology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other surgical oncology in Charlottesville
- Allan TsungCharlottesville$12K
- Victor ZaydfudimCharlottesville$10K
- Shayna ShowalterCharlottesville$5K
- Russell WittCharlottesville$368
- Craig SlingluffCharlottesville$82
- Samantha RuffCharlottesville$39
- Anneke SchroenCharlottesville$0
- David BreninCharlottesville$0
- John NiederhuberFalls Church$290K
- Shawna WilleyFairfax$213K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.